UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies

EJHaem, 2024-06, Vol.5 (3), p.560-564

2024

Volltextzugriff (PDF)

A phase II study of tacrolimus and thymoglobulin as graft‐versus‐host‐disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

American journal of hematology, 2018-04, Vol.93 (4), p.E96-E98

2018

Volltextzugriff (PDF)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2326384-2326384

2024

Volltextzugriff (PDF)

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation

Case reports in genetics, 2022-03, Vol.2022, p.6977041-5

2022

Volltextzugriff (PDF)

Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2020-12, Vol.20 (12), p.804-812.e8

2020

Volltextzugriff (PDF)

Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia

Leukemia & lymphoma, 2020-06, Vol.61 (7), p.1702-1708

2020

Volltextzugriff (PDF)

Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2020-03, Vol.20 (3), p.e131-e136

2020

Volltextzugriff (PDF)

Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients

Clinical lymphoma, myeloma and leukemia, 2020-10, Vol.20 (10), p.e685-e690

2020

Volltextzugriff (PDF)

Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy

Clinical lymphoma, myeloma and leukemia, 2020-05, Vol.20 (5), p.e239-e258

2020

Volltextzugriff (PDF)

Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia

Journal of geriatric oncology, 2022-07, Vol.13 (6), p.871-874

2022

Volltextzugriff (PDF)

Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients

Future oncology (London, England), 2019-06, Vol.15 (17), p.1989-1995

2019

Volltextzugriff (PDF)

PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients

PloS one, 2017-09, Vol.12 (9), p.e0184254-e0184254

2017

Volltextzugriff (PDF)

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB‐B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

HemaSphere, 2023-08, Vol.7 (S3), p.e2941723-n/a

2023

Volltextzugriff (PDF)

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

Supportive care in cancer, 2013-09, Vol.21 (9), p.2437-2442

2013

Volltextzugriff (PDF)

Lambert–Eaton syndrome with large‐cell neuroendocrine carcinoma of the lung

Muscle & nerve, 2008-06, Vol.37 (6), p.786-789

2008

Volltextzugriff (PDF)

Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant

Journal of clinical apheresis, 2014-12, Vol.29 (6), p.293-298

2014

Volltextzugriff (PDF)

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial

Supportive care in cancer, 2012-10, Vol.20 (10), p.2363-2369

2012

Volltextzugriff (PDF)

Role of myeloid-derived suppressor cells in tumor recurrence

Cancer and metastasis reviews, 2023-03, Vol.42 (1), p.113-142

2023

Volltextzugriff (PDF)

Highlights into historical and current immune interventions for cancer

International immunopharmacology, 2023-04, Vol.117, p.109882-109882, Article 109882

2023

Volltextzugriff (PDF)

Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.5848-5848

2023

Volltextzugriff (PDF)

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.5910-5910

2023

Volltextzugriff (PDF)

Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.7052-7052

2023

Volltextzugriff (PDF)

Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia

Leukemia research, 2024-04, Vol.139, p.107467-107467, Article 107467

2024

Volltextzugriff (PDF)

Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia

Leukemia & lymphoma, 2024-07, p.1-3

2024

Volltextzugriff (PDF)

Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy

International immunopharmacology, 2022-12, Vol.113, p.109387-109387, Article 109387

2022

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(141)
Berichte
(2)

Sprache

Englisch
(143)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Humans
(41)
Hematology
(30)
Middle Aged
(25)
Female
(24)
Male
(22)
Aged
(19)
Oncology
(19)
Immunology
(17)
Transplantation
(17)
Adult
(16)
Hematology, Oncology And Palliative Medicine
(13)
Hematopoietic Stem Cell Transplantation
(12)
Retrospective Studies
(12)
Stem Cell Transplantation
(10)
Graft Vs Host Disease - Prevention & Control
(9)
Acute Myeloid Leukemia
(8)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(8)
Graft Vs Host Disease - Etiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies

A phase II study of tacrolimus and thymoglobulin as graft‐versus‐host‐disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation

Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia

Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia

Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia

Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients

Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy

Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia

Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients

PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB‐B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

Lambert–Eaton syndrome with large‐cell neuroendocrine carcinoma of the lung

Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial

Role of myeloid-derived suppressor cells in tumor recurrence

Highlights into historical and current immune interventions for cancer

Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies

Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia

Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia

Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy

Suchergebnisse filtern